Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Intimate physical contact between people from different households during the COVID-19 pandemic: a mixed-methods study from a large, quasi-representative survey (Natsal-COVID).
Sonnenberg, P; Menezes, D; Freeman, L; Maxwell, KJ; Reid, D; Clifton, S; TANTON, C; Copas, A; Riddell, J; Dema, E; Bosó Pérez, R; Gibbs, J; Ridge, M-C; MACDOWALL, W; Unemo, M; BONELL, C; Johnson, AM; Mercer, CH; Mitchell, K; Field, N;
2022
BMJ open, (2022).12 2 10.1136/bmjopen-2021-055284.
Shielding individuals at high risk of COVID-19: a micro-simulation study.
VAN ZANDVOORT, K; Favas, C; Checchi, F;
2022
medRxiv (2022). 10.1101/2022.01.03.22268675.
Methodology of Natsal-COVID Wave 1: a large, quasi-representative survey with qualitative follow-up measuring the impact of COVID-19 on sexual and reproductive health in Britain.
Dema, E; Copas, AJ; Clifton, S; Conolly, A; Blake, M; Riddell, J; Boso Perez, R; TANTON, C; BONELL, C; Sonnenberg, P; Mercer, CH; Mitchell, KR; Field, N;
2022
Wellcome open research, (2022).6, 10.12688/wellcomeopenres.16963.1.
Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study...
ARASHIRO, T; Arima, Y; Muraoka, H; Sato, A; Oba, K; Uehara, Y; Arioka, H; Yanai, H; Kuramochi, J; Ihara, G; Chubachi, K; Yanagisawa, N; Nagura, Y; Kato, Y; Ueda, A; Numata, A; Kato, H; Ishii, K; Ooki, T; Oka, H; Nishida, Y; Stucky, A; SMITH, C; HIBBERD, M; Ariyoshi, K; ... Suzuki, M.
2022
Clinical Infectious Diseases, (2022).76 3 10.1093/cid/ciac635.
Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies.
Fu, Y; Zhao, J; Wei, X; Han, P; Yang, L; Ren, T; Zhan, S; Li, L;
2022
Frontiers in public health, (2022).10, 10.3389/fpubh.2022.917732.
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
Liu, X; Munro, AP S; Feng, S; Janani, L; Aley, PK; Babbage, G; Baxter, D; Bula, M; Cathie, K; Chatterjee, K; Dejnirattisai, W; Dodd, K; Enever, Y; Qureshi, E; Goodman, AL; Green, CA; Harndahl, L; Haughney, J; Hicks, A; Van der Klaauw, AA; Kwok, J; Libri, V; Llewelyn, MJ; McGregor, AC; Minassian, AM; ... COV-BOOST study group,
2022
The Journal of infection, (2022).84 6 10.1016/j.jinf.2022.04.018.
Assessment of Cardiac, Vascular, and Pulmonary Pathobiology In Vivo During Acute COVID-19.
Alam, SR; Vinayak, S; Shah, A; Doolub, G; Kimeu, R; Horn, KP; Bowen, SR; Jeilan, M; Lee, KK; Gachoka, S; Riunga, F; Adam, RD; Vesselle, H; Joshi, N; Obino, M; Makhdomi, K; Ombati, K; Nganga, E; Gitau, S; Chung, MH; SHAH, AS V;
2022
Journal of the American Heart Association, (2022).11 18 10.1161/JAHA.122.026399.
The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence.
Carle, C; Hughes, S; Freeman, V; Campbell, D; Egger, S; Caruana, M; Hui, H; Yap, S; Deandrea, S; Onyeka, TC; IJzerman, MJ; Ginsburg, O; Bray, F; Sullivan, R; AGGARWAL, A; Peacock, SJ; Chan, KK W; Hanna, TP; Soerjomataram, I; O'Connell, DL; Canfell, K; Steinberg, J;
2022
Journal of Cancer Policy, (2022).33, 10.1016/j.jcpo.2022.100338.
Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before-after cohort study using mixed effects regression.
Pry, JM; SIKOMBE, K; Mody, A; Iyer, S; Mutale, J; Vlahakis, N; Savory, T; Wa Mwanza, M; Mweebo, K; Mwila, A; Mwale, C; Mukumbwa-Mwenechanya, M; Kerkhoff, AD; Sikazwe, I; Bolton Moore, C; Mwamba, D; Geng, EH; Herce, ME;
2022
BMJ global health, (2022).7 1 10.1136/bmjgh-2021-007312.
Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis.
LIU, Y; PEARSON, CA B; Sandmann, FG; BARNARD, RC; Kim, J-H; CMMID COVID-19 Working Group,; FLASCHE, S; JIT, M; ABBAS, K;
2022
The Lancet Regional Health - Europe, (2022).17, 10.1016/j.lanepe.2022.100381.